4-((2-(2-((4-Methoxyphenyl)amino)-2-oxoacetyl)hydrazono)methyl)phenyl 2-bromobenzoate

Catalog No. :
ACLZAV517
CAS No. :
594852-22-9
Molecular Formula :
C23H18BrN3O5
Molecular Weight :
496.32

IUPAC Name:(E)-4-((2-(2-((4-methoxyphenyl)amino)-2-oxoacetyl)hydrazineylidene)methyl)phenyl 2-bromobenzoate

4-((2-(2-((4-Methoxyphenyl)amino)-2-oxoacetyl)hydrazono)methyl)phenyl 2-bromobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((2-(2-((4-Methoxyphenyl)amino)-2-oxoacetyl)hydrazono)methyl)phenyl 2-bromobenzoate
IUPAC Name(E)-4-((2-(2-((4-methoxyphenyl)amino)-2-oxoacetyl)hydrazineylidene)methyl)phenyl 2-bromobenzoate
MDL No.MFCD03897647
Molecular FormulaC23H18BrN3O5
Molecular Weight496.32
SMILESO=C(OC1=CC=C(/C=N/NC(C(NC2=CC=C(OC)C=C2)=O)=O)C=C1)C3=CC=CC=C3Br
InChI KeyOSTHYJMGTFPLCF-AFUMVMLFSA-N
SynonymSALOR-INT L396060-1EA;4-(2-((4-METHOXYANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENYL 2-BROMOBENZOATE
CAS No.594852-22-9

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P273-P301+P312-P305+P351+P338-P314

Synthetic Route by SureRoute

1. ACLZAV517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZAV517 route product structure diagram
    ACLZAV517594852-22-9
Inquiry

2. ACLZAV517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIQEY824 route compound structure diagram
    ACIQEY82420580-47-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZAV517 route product structure diagram
    ACLZAV517594852-22-9
Inquiry

Comments (0)